Stocktoria
Galenica AG GALE.SW
Galenica AG (GALE.SW) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 2.73% (safety: stretched). FY2025 revenue was CHF 4.1B at a 4.4% net margin.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
About Galenica AG
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; laboratory medicine, pathology and specialized personalized diagnostic services; and develops, markets, and sells healthcare services and products through various distribution channels. The Logistics & IT segment provides various specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data systems for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as offers complete management solutions for pharmacies. In addition, it provides on-schedule delivery services to pharmacies, drugstores, doctors, hospitals, and care homes. The company was founded in 1927 and is headquartered in Bern, Switzerland.
How it ranks in Healthcare · percentile among 73 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.042 |
| Retained earnings / assets | 0.453 |
| EBIT / assets | 0.069 |
| Equity / liabilities | 0.818 |
FAQ
Is GALE.SW financially healthy?
Galenica AG's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does GALE.SW pay a dividend, and is it safe?
Yes. Galenica AG pays a dividend yielding about 2.73% with a 63.6% payout ratio, rated “stretched” for safety.
How profitable is GALE.SW?
In FY2025, Galenica AG had a net margin of 4.4% and a return on equity of 12.2%.
Computed from company filings · CH · as of 2025-12-31. Figures in CHF. Facts plus Stocktoria's own computed scores — not investment advice.